450 related articles for article (PubMed ID: 14752841)
1. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
[TBL] [Abstract][Full Text] [Related]
2. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
Tamada S; Shibahara H; Higashi M; Goto M; Batra SK; Imai K; Yonezawa S
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4257-64. PubMed ID: 16857800
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF
Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442
[TBL] [Abstract][Full Text] [Related]
4. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
[TBL] [Abstract][Full Text] [Related]
6. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.
Tsutsumida H; Goto M; Kitajima S; Kubota I; Hirotsu Y; Wakimoto J; Batra SK; Imai K; Yonezawa S
Lung Cancer; 2007 Feb; 55(2):195-203. PubMed ID: 17126950
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
[TBL] [Abstract][Full Text] [Related]
9. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
[TBL] [Abstract][Full Text] [Related]
11. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M
Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.
Shimada K; Sano T; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
Surgery; 2009 Apr; 145(4):411-6. PubMed ID: 19303990
[TBL] [Abstract][Full Text] [Related]
13. MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma.
Weed DT; Gomez-Fernandez C; Pacheco J; Ruiz J; Hamilton-Nelson K; Arnold DJ; Civantos FJ; Zhang J; Yasin M; Goodwin WJ; Carraway KL
Head Neck; 2004 Apr; 26(4):353-64. PubMed ID: 15054739
[TBL] [Abstract][Full Text] [Related]
14. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F
Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816
[TBL] [Abstract][Full Text] [Related]
15. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
[TBL] [Abstract][Full Text] [Related]
16. MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes.
Weed DT; Gomez-Fernandez C; Yasin M; Hamilton-Nelson K; Rodriguez M; Zhang J; Carraway KL
Laryngoscope; 2004 Aug; 114(8 Pt 2 Suppl 101):1-32. PubMed ID: 15284539
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
[TBL] [Abstract][Full Text] [Related]
18. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
Su MC; Hsu C; Kao HL; Jeng YM
Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
[TBL] [Abstract][Full Text] [Related]
19. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
Paik KY; Jung JC; Heo JS; Choi SH; Choi DW; Kim YI
J Gastroenterol Hepatol; 2008 May; 23(5):766-70. PubMed ID: 17868336
[TBL] [Abstract][Full Text] [Related]
20. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
